Trex (TREX) & The Competition Critical Contrast
Trex (NYSE:TREX – Get Free Report) is one of 93 public companies in the “Building Products” industry, but how does it compare to its competitors? We will compare Trex to related businesses based on the strength of its analyst recommendations, earnings, valuation, profitability, institutional ownership, risk and dividends. Volatility and Risk Trex has a beta […]
Contrasting Lamar Advertising (LAMR) and The Competition
Lamar Advertising (NASDAQ:LAMR – Get Free Report) is one of 35 publicly-traded companies in the “Specialized REITs” industry, but how does it weigh in compared to its competitors? We will compare Lamar Advertising to similar businesses based on the strength of its profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Profitability This table […]
Amarin (AMRN) vs. The Competition Critical Contrast
Amarin (NASDAQ:AMRN – Get Free Report) is one of 897 publicly-traded companies in the “Pharmaceuticals” industry, but how does it compare to its competitors? We will compare Amarin to related businesses based on the strength of its dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability. Risk & Volatility Amarin has a beta of […]
Critical Contrast: Theravance Biopharma (TBPH) vs. The Competition
Theravance Biopharma (NASDAQ:TBPH – Get Free Report) is one of 897 publicly-traded companies in the “Pharmaceuticals” industry, but how does it compare to its competitors? We will compare Theravance Biopharma to related businesses based on the strength of its dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability. Risk & Volatility Theravance Biopharma has […]
last updated on 7 Nov 04:46